Octane - About the company
Octane is an acquired company based in Kingston (Canada), founded in 2007 by Timothy Smith and Ian Grant. It operates as a Provider of advanced bioreactors, bioprocesses, and biomaterials to enable cell and tissue culture for regenerative medicine. The company has 1972 active competitors, including 449 funded and 319 that have exited. Its top competitors include companies like Antheia, Transcenta and Akeso.
Company Details
Provider of advanced bioreactors, bioprocesses, and biomaterials to enable cell and tissue culture for regenerative medicine. Its proprietary platform called Octane Cocoon which is a patient scale cell therapy system which can be coupled to the bioreactors, and cell scaffolds to automate the production of therapy-specific cell suspensions for cell therapy and cell-based tissue implants. It is also partnering with cell therapy and medical devices companies to address unmet needs in regenerative medicine.
- Website
- www.octaneco.com/
- Email ID
- *****@octaneco.com
Key Metrics
Founded Year
2007
Location
Kingston, Canada
Stage
Acquired
Ranked
178th among 1972 active competitors
Employee Count
85 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Acquired by Lonza (Oct 29, 2018)
Octane's acquisition details
Octane got acquired by Lonza on Oct 29, 2018.
Click here to take a look at Octane's acquisition in detail
Sign up to download Octane's company profile
Octane's funding and investors
Octane has not raised any funding rounds yet.
Octane's founders and board of directors
Founder? Claim ProfileHere are the details of Octane's key team members:
- Timothy Smith: Co-Founder & CEO of Octane. They serve on the board of 1 company.Contact Info: 1 email address
- Ian Grant: Co-Founder & COO of Octane. Contact Info: 1 email address
View details of Octane's Founder profiles and Board Members
Octane's employee count trend
Octane has 85 employees as of Sep 26. Here is Octane's employee count trend over the years:
Uncover Octane's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Octane's Competitors and alternates
Top competitors of Octane include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Octane, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
2nd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
3rd | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
4th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
5th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 64/100 | |
6th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
7th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
8th | LifeMine Therapeutics 2016, Watertown (United States), Series E | Developer of novel drugs from fungi via genome mining and recombinant overexpression | $563M | 62/100 | |
9th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
10th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
178th | Provider of advanced bioreactors, bioprocesses, and biomaterials to enable cell and tissue culture for regenerative medicine | - | - | 44/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Octane's competitors? Click here to see the top ones
Octane's Investments and acquisitions
Octane has a total of 1 investment in Inspire Biotherapeutics. Octane has not made any acquisitions as of now.Reports related to Octane
Here is the latest report on Octane's sector:
News related to Octane
Media has covered Octane for 1 event in last 1 year, It was about partnerships.
•
BioOra and Octane Biotech Partner to Expand Cell Therapy ManufacturingGlobeNewswire•Apr 07, 2026•BioOra, Octane, Octane Biotech
•
Octane Group’s Acquisition Of TETEC From Aesculap AGGlobal Legal Chronicle•Jul 05, 2024•Octane, Tetec-Ag, Osborne Clarke, Aesculap (US)
•
Octane Medical acquires B. Braun's global orthobiologics businessBenzinga•Jun 07, 2024•octanemedical.com, B Braun, Octane, Tetec-Ag and 1 other
•
•
Lonza Further Strengthens Focus on Its Healthcare Continuum Strategy by Signing Agreement to Divest Water Care Business to Platinum EquityPlatinum Equity•Nov 01, 2018•Platinum Equity, Lonza, Lonza Water Treatment, Octane and 1 other
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Octane
Explore our recently published companies
- Mokopro - Unfunded company
- Aecc - Melbourne based, 2008 founded, Unfunded company
- handlie - Portugal based, Unfunded company
- HomeTek Services - Arlington based, Unfunded company
- Yonivers - France based, 2014 founded, Unfunded company
- Arabian Sands - Dubai based, 2014 founded, Unfunded company
